Phase 3 Wheezing Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
AsthmaWheezing
Sanofi90 enrolled74 locationsNCT06191315
Recruiting
Phase 3
Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma
AsthmaFractures, BoneAllergy+8 more
Professor Klaus Bønnelykke2,000 enrolled1 locationNCT06560255
Recruiting
Phase 3
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
AsthmaFractures, BoneAllergy+8 more
Professor Klaus Bønnelykke2,000 enrolled1 locationNCT06570889
Recruiting
Phase 3
Protecting Preterm Infants From Respiratory Tract Infections and Wheeze by Using Bacterial Lysates.
WheezingPrematureLRTI
Franciscus Gasthuis500 enrolled1 locationNCT05063149
Not Yet Recruiting
Phase 3
POWER: Prevention with OM-85 of wheezing exacerbation recurrence trial..
acute wheezing
the University of Western Australia200 enrolled2 locationsACTRN12619000864123